Tuesday, August 28, 2018

Duzallo®, a Fixed-dose Combination Therapy for Gout, Approved in Europe

AACHEN, Germany, August 28, 2018 /PRNewswire/ -- Today, Grünenthal announced that the European Commission has followed the positive opinion of the Committee for Medicinal Products for Human Use (CHMP) and granted Duzallo® marketing authorization for the EU/EEA. Duzallo® is a...

from PR Newswire: //https://ift.tt/2wssqsB

No comments:

Post a Comment